Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Operating Leases (2022 - 2025)

GeneDx Holdings has reported Operating Leases over the past 4 years, most recently at $60.4 million for Q4 2025.

  • Quarterly results put Operating Leases at $60.4 million for Q4 2025, down 0.77% from a year ago — trailing twelve months through Dec 2025 was $60.4 million (down 0.77% YoY), and the annual figure for FY2025 was $60.4 million, down 0.77%.
  • Operating Leases for Q4 2025 was $60.4 million at GeneDx Holdings, up from $57.2 million in the prior quarter.
  • Over the last five years, Operating Leases for WGSWW hit a ceiling of $63.9 million in Q3 2023 and a floor of $57.2 million in Q3 2025.
  • Median Operating Leases over the past 4 years was $60.9 million (2024), compared with a mean of $61.1 million.
  • Biggest five-year swings in Operating Leases: rose 11.14% in 2023 and later decreased 5.51% in 2024.
  • GeneDx Holdings' Operating Leases stood at $60.0 million in 2022, then increased by 4.87% to $62.9 million in 2023, then dropped by 3.21% to $60.9 million in 2024, then decreased by 0.77% to $60.4 million in 2025.
  • The last three reported values for Operating Leases were $60.4 million (Q4 2025), $57.2 million (Q3 2025), and $59.6 million (Q2 2025) per Business Quant data.